Localisation of N-acetylaspartate in oligodendrocytes/myelin

The role of N-acetylaspartate in the brain is unclear. Here we used specific antibodies against N-acetylaspartate and immunocytochemistry of carbodiimide-fixed adult rodent brain to show that, besides staining of neuronal cell bodies in the grey matter, N-acetylaspartate labelling was present in oligodendrocytes/myelin in white matter tracts. Immunoelectron microscopy of the rat hippocampus showed that N-acetylaspartate was concentrated in the myelin. Also neuronal cell bodies and axons contained significant amounts of N-acetylaspartate, while synaptic elements and astrocytes were low in N-acetylaspartate. Mitochondria in axons and neuronal cell bodies contained higher levels of N-acetylaspartate compared to the cytosol, compatible with synthesis of N-acetylaspartate in mitochondria. In aspartoacylase knockout mice, in which catabolism of N-acetylaspartate is blocked, the levels of N-acetylaspartate were largely increased in oligodendrocytes/myelin. In these mice, the highest myelin concentration of N-acetylaspartate was found in the cerebellum, a region showing overt dysmyelination. In organotypic cortical slice cultures there was no evidence for N-acetylaspartate-induced myelin toxicity, supporting the notion that myelin damage is induced by the lack of N-acetylaspartate for lipid production. Our findings also implicate that N-acetylaspartate signals on magnetic resonance spectroscopy reflect not only vital neurons but also vital oligodendrocytes/myelin.

[1]  H. Tallan,et al.  N-Acetyl-L-aspartic acid in brain. , 1956, The Journal of biological chemistry.

[2]  F. Fonnum,et al.  SUBCELLULAR LOCALIZATION OF N‐ACETYL‐ASPARTYL‐GLUTAMATE, N‐ACETYL‐GLUTAMATE AND GLUTATHIONE IN BRAIN , 1969, Journal of neurochemistry.

[3]  K. Daneshbod,et al.  Familial spongy degeneration of the brain. , 1970, Archives of neurology.

[4]  M. Adachi,et al.  Electron microscopic and enzyme histochemical studies of the cerebellum in spongy degeneration (van Bogaert and Bertrans type). , 1972, Acta neuropathologica.

[5]  T. Patel,et al.  Synthesis of N-acetyl-L-aspartate by rat brain mitochondria and its involvement in mitochondrial/cytosolic carbon transport. , 1979, The Biochemical journal.

[6]  J. Storm-Mathisen,et al.  Glutamate‐ and GABA‐containing neurons in the mouse and rat brain, as demonstrated with a new immunocytochemical technique , 1984, The Journal of comparative neurology.

[7]  M. Brownstein,et al.  N‐Acetylation of L‐Aspartate in the Nervous System: Differential Distribution of a Specific Enzyme , 1985, Journal of neurochemistry.

[8]  R. Kaul,et al.  Purification, Characterization, and Localization of Aspartoacylase from Bovine Brain , 1991, Journal of neurochemistry.

[9]  N. Herschkowitz,et al.  N-acetyl-L-aspartate is a major source of acetyl groups for lipid synthesis during rat brain development. , 1991, Developmental neuroscience.

[10]  J. Coyle,et al.  Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies , 1991, Neuroscience.

[11]  J. Neale,et al.  Immunohistochemical localization of N-acetylaspartate in rat brain. , 1991, Neuroreport.

[12]  J. Neale,et al.  Enhanced carbodiimide fixation for immunohistochemistry: application to the comparative distributions of N-acetylaspartylglutamate and N-acetylaspartate immunoreactivities in rat brain. , 1993, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[13]  R. Kaul,et al.  Cloning of the human aspartoacylase cDNA and a common missense mutation in Canavan disease , 1993, Nature genetics.

[14]  A Heerschap,et al.  Standardized method for high-resolution 1H-NMR of cerebrospinal fluid. , 1995, Clinical chemistry.

[15]  G Tedeschi,et al.  Brain regional distribution pattern of metabolite signal intensities in young adults by proton magnetic resonance spectroscopic imaging , 1995, Neurology.

[16]  J. Coyle,et al.  N-Acetylaspartate in neuropsychiatric disorders , 1995, Progress in Neurobiology.

[17]  J. Moffett,et al.  Differential distribution of N-acetylaspartylglutamate and N-acetylaspartate immunoreactivities in rat forebrain , 1995, Journal of neurocytology.

[18]  P. Matthews,et al.  Chemical pathology of acute demyelinating lesions and its correlation with disability , 1995, Annals of neurology.

[19]  M. Namboodiri,et al.  N-acetylaspartate as an acetyl source in the nervous system. , 1995, Brain research. Molecular brain research.

[20]  J. Duyn,et al.  Quantitative proton MR spectroscopic imaging of the human brain , 1996, Magnetic resonance in medicine.

[21]  M. Gotoh,et al.  Brain Tissue Acidosis: Effects on the Extracellular Concentration of N‐Acetylaspartate , 1997, Journal of neurochemistry.

[22]  J S Wolinsky,et al.  Serial proton magnetic resonance spectroscopic imaging, contrast‐enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis , 1998, Annals of neurology.

[23]  F. Fonnum,et al.  Synaptic Vesicular Localization and Exocytosis ofl-Aspartate in Excitatory Nerve Terminals: A Quantitative Immunogold Analysis in Rat Hippocampus , 1998, The Journal of Neuroscience.

[24]  A. Sewell,et al.  N-acetylaspartylglutamate in Canavan disease: an adverse effector? , 1999, European Journal of Pediatrics.

[25]  R. Matalon,et al.  Knock‐out mouse for Canavan disease: a model for gene transfer to the central nervous system , 2000, The journal of gene medicine.

[26]  K. Bhakoo,et al.  In Vitro Expression of N‐Acetyl Aspartate by Oligodendrocytes , 2000, Journal of neurochemistry.

[27]  K. Houkin,et al.  Reversible brain dysfunction in MELAS: MEG, and 1H MRS analysis , 2001, Journal of neurology, neurosurgery, and psychiatry.

[28]  M W Weiner,et al.  Region and tissue differences of metabolites in normally aged brain using multislice 1H magnetic resonance spectroscopic imaging , 2001, Magnetic resonance in medicine.

[29]  P M Matthews,et al.  N‐acetylaspartate: Usefulness as an indicator of viable neuronal tissue , 2001, Annals of neurology.

[30]  J Hennig,et al.  Absence of N‐acetylaspartate in the human brain: Impact on neurospectroscopy? , 2001, Annals of neurology.

[31]  R. Ledeen,et al.  Intraneuronal N‐acetylaspartate supplies acetyl groups for myelin lipid synthesis: evidence for myelin‐associated aspartoacylase , 2001, Journal of neurochemistry.

[32]  R. Ledeen,et al.  Fatty acid synthesizing enzymes intrinsic to myelin. , 2003, Brain research. Molecular brain research.

[33]  C. N. Madhavarao,et al.  Characterization of the N‐acetylaspartate biosynthetic enzyme from rat brain , 2003, Journal of neurochemistry.

[34]  T. Serikawa,et al.  Identification and distribution of aspartoacylase in the postnatal rat brain , 2003, Neuroreport.

[35]  R. Matalon,et al.  Molecular Basis of Canavan's Disease , 2003, Journal of child neurology.

[36]  R. Wevers,et al.  Follow-up of a child with hypoacetylaspartia. , 2004, Neuropediatrics.

[37]  M. Adachi,et al.  Electron miscroscopic and enzyme histochemical studies of the cerebellum in spongy degeneration , 2004, Acta Neuropathologica.

[38]  D. Jacobowitz,et al.  Immunohistochemical localization of aspartoacylase in the rat central nervous system , 2004, The Journal of comparative neurology.

[39]  J. Moffett,et al.  Defective N-acetylaspartate catabolism reduces brain acetate levels and myelin lipid synthesis in Canavan's disease. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[40]  D. Attwell,et al.  NMDA receptors are expressed in oligodendrocytes and activated in ischaemia , 2005, Nature.

[41]  A Freese,et al.  Natural History of Canavan Disease Revealed by Proton Magnetic Resonance Spectroscopy (1H‐MRS) and Diffusion-weighted MRI , 2006, Neuropediatrics.

[42]  J. Moffett,et al.  Expression of N-acetylaspartate and N-acetylaspartylglutamate in the nervous system. , 2006, Advances in experimental medicine and biology.

[43]  D. Jacobowitz,et al.  Defective myelin lipid synthesis as a pathogenic mechanism of Canavan disease. , 2006, Advances in experimental medicine and biology.

[44]  A. De Simoni,et al.  Preparation of organotypic hippocampal slice cultures: interface method , 2006 .

[45]  R. Ledeen,et al.  Axon-myelin transfer of phospholipids and phospholipid precursors , 1992, Molecular Neurobiology.

[46]  Morris H. Baslow,et al.  Brain N-acetylaspartate as a molecular water pump and its role in the etiology of canavan disease , 2007, Journal of Molecular Neuroscience.

[47]  J. Greenfield,et al.  Schilder's Encephalitis (Encephalitis Periaxialis Diffusa) , 1926 .

[48]  R. Matalon,et al.  Bimodal occurrence of aspartoacylase in myelin and cytosol of brain , 2007, Journal of neurochemistry.

[49]  T. Serikawa,et al.  Myelin Lipid Abnormalities in the Aspartoacylase-Deficient Tremor Rat , 2008, Neurochemical Research.

[50]  B. Barres,et al.  Nur7 Is a Nonsense Mutation in the Mouse Aspartoacylase Gene That Causes Spongy Degeneration of the CNS , 2008, The Journal of Neuroscience.

[51]  R. Reynolds,et al.  Normal-appearing white matter in multiple sclerosis is in a subtle balance between inflammation and neuroprotection. , 2007, Brain : a journal of neurology.

[52]  J. Storm-Mathisen,et al.  Immunogold quantification of amino acids and proteins in complex subcellular compartments , 2008, Nature Protocols.

[53]  P. Courtoy,et al.  Molecular identification of aspartate N-acetyltransferase and its mutation in hypoacetylaspartia. , 2009, The Biochemical journal.

[54]  J. Moffett,et al.  Evidence for mitochondrial and cytoplasmic N-acetylaspartate synthesis in SH-SY5Y neuroblastoma cells , 2009, Neurochemistry International.

[55]  T. Ben-Hur,et al.  Transplanted Neural Precursors Enhance Host Brain-Derived Myelin Regeneration , 2009, The Journal of Neuroscience.

[56]  D. Attwell,et al.  The effect of N-acetyl-aspartyl-glutamate and N-acetyl-aspartate on white matter oligodendrocytes , 2009, Brain : a journal of neurology.

[57]  N. Pattabiraman,et al.  Methamphetamine-induced neuronal protein NAT8L is the NAA biosynthetic enzyme: Implications for specialized acetyl coenzyme A metabolism in the CNS , 2010, Brain Research.

[58]  Howard Y. Chang,et al.  G1 arrest and differentiation can occur independently of Rb family function , 2010, The Journal of cell biology.

[59]  K. P. Lehre,et al.  The perivascular astroglial sheath provides a complete covering of the brain microvessels: An electron microscopic 3D reconstruction , 2010, Glia.

[60]  D. Bok,et al.  Aspartoacylase deficiency affects early postnatal development of oligodendrocytes and myelination , 2010, Neurobiology of Disease.

[61]  A. Sartorius,et al.  Aspartoacylase-LacZ Knockin Mice: An Engineered Model of Canavan Disease , 2011, PloS one.

[62]  D. Jacobowitz,et al.  Extensive aspartoacylase expression in the rat central nervous system , 2011, Glia.

[63]  D. Attwell,et al.  Regulation of Oligodendrocyte Development and Myelination by Glucose and Lactate , 2011, The Journal of Neuroscience.

[64]  J. E. Rinholm,et al.  Neuroscience: The wrap that feeds neurons , 2012, Nature.

[65]  Pierre J. Magistretti,et al.  Oligodendroglia metabolically support axons and contribute to neurodegeneration , 2012, Nature.

[66]  M. Bates,et al.  The Actin-Severing Protein Cofilin Is Downstream of Neuregulin Signaling and Is Essential For Schwann Cell Myelination , 2012, The Journal of Neuroscience.

[67]  V. Gundersen,et al.  A distinct set of synaptic‐like microvesicles in atroglial cells contain VGLUT3 , 2012, Glia.

[68]  V. Gundersen,et al.  VGLUT1 is localized in astrocytic processes in several brain regions , 2012, Glia.

[69]  N-Acetylaspartate (NAA) and N-acetylaspartylglutamate (NAAG) promote growth and inhibit differentiation of glioma stem-like cells. , 2013, The Journal of Biological Chemistry.

[70]  P. M. Long,et al.  N-Acetylaspartate (NAA) and N-Acetylaspartylglutamate (NAAG) Promote Growth and Inhibit Differentiation of Glioma Stem-like Cells* , 2013, The Journal of Biological Chemistry.